Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging

References

1. ↵
   Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172–79

   CrossRefPubMed
2. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005;26:1178–85

   Abstract/FREE Full Text
3. ↵
   Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr 2003;27:687–93

   CrossRefPubMed
4. ↵
   Hermans R, Lambin P, Van den Bogaert W, et al. Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997;44:159–62

   CrossRefPubMed
5. ↵
   Gandhi D, Chepeha DB, Miller T, et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101–06

   Abstract/FREE Full Text
6. ↵
   Zima A, Carlos R, Gandhi D, et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

   Abstract/FREE Full Text
7. ↵
   Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457–61

   PubMedWeb of Science
8. ↵
   Hirasawa S, Tsushima Y, Takei H, et al. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. Acad Radiol 2007;14:312–18

   CrossRefPubMed
9. ↵
   Stewart EE, Chen X, Hadway J, et al. Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model. Radiology 2006;239:740–50

   CrossRefPubMedWeb of Science
10. ↵
    Tateishi U, Nishihara H, Tsukamoto E, et al. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002;26:185–90

    CrossRefPubMed
11. ↵
    Downey RJ, Akhurst T, Gonen M, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255–60

    Abstract/FREE Full Text
12. ↵
    Halligan S. Reproducibility, repeatability, correlation and measurement error. Br J Radiol 2002;75:193–194; author reply 194–195

    FREE Full Text
13. ↵
    Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837–44

    Abstract/FREE Full Text
14. ↵
    de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79–87

    CrossRefPubMedWeb of Science
15. ↵
    Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003;97:1015–24

    CrossRefPubMedWeb of Science
16. ↵
    Maia AC, Jr., Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777–83

    Abstract/FREE Full Text
17. ↵
    Kosaka N, Uematsu H, Kimura H, et al. Assessment of the vascularity of uterine leiomyomas using double-echo dynamic perfusion-weighted MRI with the first-pass pharmacokinetic model: correlation with histopathology. Invest Radiol 2007;42:629–35

    CrossRefPubMed
18. ↵
    Rajendran JG, Mankoff DA, O'Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 2004;10:2245–52

    Abstract/FREE Full Text
19. ↵
    van Laarhoven HW, de Geus-Oei LF, Wiering B, et al. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET. Radiology 2005;237:181–88

    PubMed
20. ↵
    Rajendran JG, Schwartz DL, O'Sullivan J, et al. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 2006;12:5435–41

    Abstract/FREE Full Text
21. ↵
    Sorensen M, Horsman MR, Cumming P, et al. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 2005;62:854–61

    CrossRefPubMed
22. ↵
    Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:22–28

    PubMedWeb of Science
23. ↵
    Hermans R, Meijerink M, Van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57:1351–56

    CrossRefPubMedWeb of Science
24. ↵
    Warburg O. On the origin of cancer cells. Science 1956;123:309–14

    FREE Full Text
25. ↵
    Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002;43:500–09

    Abstract/FREE Full Text
26. ↵
    Hunter GJ, Hamberg LM, Choi N, et al. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism. Clin Cancer Res 1998;4:949–55

    Abstract
27. ↵
    Mamede M, Higashi T, Kitaichi M, et al. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 2005;7:369–79

    CrossRefPubMedWeb of Science
28. ↵
    Bisdas S, Konstantinou GN, Lee PS, et al. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis. Phys Med Biol 2007;52:6181–96

    CrossRefPubMed
29. ↵
    Son JM, Ahn MI, Cho KD, et al. Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT. Br J Radiol 2007;80:e222–26

    Abstract/FREE Full Text
30. ↵
    Schwartz DL, Rajendran J, Yueh B, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 2004;130:1361–67

    CrossRefPubMedWeb of Science
31. ↵
    Lee SW, Nam SY, Im KC, et al. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 2008;87:211–16. Epub 2008 Jan 30

    CrossRefPubMedWeb of Science